The Remarkable Story of Copaxone®
An Approach to the Treatment of Multiple Sclerosis
- List Price$14.99
- Your price$11.99
Save $3.00 (20% off) and earn Kobo Super Points!
You'll see how many points you'll earn before checking out. We'll award them after completing your purchase.
Or, get it for 6800 Kobo Super Points!
See if you have enough points for this eBook. Sign in
Multiple sclerosis (MS) is the most common crippling neurologic disease of young adults. Its course is unpredictable; people with the disease never know when new symptoms may appear or if improvement will follow. Virtually every therapy for any human disease had been considered and tried, without finding a useful treatment. This understandably led to despair for people with MS and to frustration and disappointment for clinicians.
The development of Copaxone® is among the most unique of modern drug discoveries. Not only is it the enduring legacy of brilliant and determined scientists working over decades; it is also the story of The Weizmann Institute of Science and Teva Pharmaceutical Industries Ltd., two organizations that grew and prospered in spite of a most chaotic and dangerous environment during the early years of the State of Israel. Courage, focus, and dedication to high ideals, as well as excellent science, are the essence of this story.
- DiaMedica, March 2011
- Download options:
- EPUB 2 (Adobe DRM)
You can read this item using any of the following Kobo apps and devices: